NASDAQ:CRSP

CRISPR Therapeutics SEC Filings & 10K Form

$124.52
+7.10 (+6.05 %)
(As of 09/17/2021 12:00 AM ET)
Add
Compare
Today's Range
$115.96
$124.79
50-Day Range
$116.30
$140.75
52-Week Range
$79.31
$220.20
Volume1.67 million shs
Average Volume785,794 shs
Market Capitalization$9.49 billion
P/E Ratio24.37
Dividend YieldN/A
Beta2.25

CRISPR Therapeutics (NASDAQ:CRSP) SEC Filings

DateFilerForm TypeView
09/14/2021
8:45 PM
CRISPR Therapeutics (Issuer)
KASINGER JAMES R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/14/2021
8:44 PM
CRISPR Therapeutics (Issuer)
Klein Lawrence Otto (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2021
1:47 PM
ARK Investment Management LLC (Filed by)
CRISPR Therapeutics (Subject)
Form SC 13G/A
09/03/2021
7:00 PM
CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2021
7:00 PM
CRISPR Therapeutics (Issuer)
TOMSICEK MICHAEL JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2021
11:28 AM
Capital International Investors (Filed by)
CRISPR Therapeutics (Subject)
Form SC 13G/A
08/06/2021
7:00 PM
CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/21/2021
4:21 PM
Bolzon Bradley J PhD (Reporting)
CRISPR Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2021
4:54 PM
CRISPR Therapeutics (Issuer)
Novak Rodger (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2021
4:44 PM
CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2021
3:41 PM
Bolzon Bradley J PhD (Reporting)
CRISPR Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2021
5:23 PM
Behbahani Ali (Reporting)
CRISPR Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2021
4:39 PM
CRISPR Therapeutics (Issuer)
Treco Douglas A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2021
4:39 PM
CRISPR Therapeutics (Issuer)
High Katherine A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2021
4:38 PM
CRISPR Therapeutics (Issuer)
Greene John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2021
4:37 PM
CRISPR Therapeutics (Issuer)
George Simeon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2021
4:36 PM
Bolzon Bradley J PhD (Reporting)
CRISPR Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2021
4:35 PM
CRISPR Therapeutics (Issuer)
Fleming Harold Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2021
4:32 PM
CRISPR Therapeutics (Issuer)
Fleming Harold Edward (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/11/2021
6:10 AM
CRISPR Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2021
4:34 PM
CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2021
8:16 AM
CRISPR Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/28/2021
3:22 PM
CRISPR Therapeutics (Filer)
Form DEFA14A
04/27/2021
3:19 PM
CRISPR Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/20/2021
6:22 AM
CRISPR Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/05/2021
3:18 PM
CRISPR Therapeutics (Filer)
Form PRE 14A
03/24/2021
5:00 PM
Bolzon Bradley J PhD (Reporting)
CRISPR Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2021
4:50 PM
CRISPR Therapeutics (Issuer)
TOMSICEK MICHAEL JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2021
4:49 PM
CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2021
4:47 PM
CRISPR Therapeutics (Issuer)
Klein Lawrence Otto (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2021
4:43 PM
CRISPR Therapeutics (Issuer)
KASINGER JAMES R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2021
4:41 PM
CRISPR Therapeutics (Issuer)
Ho Tony W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2021
4:37 PM
CRISPR Therapeutics (Issuer)
Klein Lawrence Otto (Reporting)
Form 4/A
03/09/2021
4:40 PM
CRISPR Therapeutics (Issuer)
Ho Tony W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2021
3:13 PM
CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2021
2:58 PM
Capital International Investors (Filed by)
CRISPR Therapeutics (Subject)
Form SC 13G/A
02/16/2021
6:33 AM
CRISPR Therapeutics (Subject)
Versant Ventures IV, LLC (Filed by)
Form SC 13D/A
02/05/2021
5:10 AM
CRISPR Therapeutics (Subject)
Sumitomo Mitsui Trust Holdings, Inc. (Filed by)
Form SC 13G/A
01/20/2021
5:11 PM
CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/20/2021
5:07 PM
CRISPR Therapeutics (Issuer)
Klein Lawrence Otto (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/20/2021
5:05 PM
CRISPR Therapeutics (Issuer)
KASINGER JAMES R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2021
3:12 PM
CRISPR Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/15/2021
3:10 PM
CRISPR Therapeutics (Filer)
Form 424B5
01/04/2021
3:12 PM
CRISPR Therapeutics (Issuer)
Klein Lawrence Otto (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2020
3:02 PM
CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2020
6:12 PM
Bolzon Bradley J PhD (Reporting)
CRISPR Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2020
6:14 PM
Bolzon Bradley J PhD (Reporting)
CRISPR Therapeutics (Issuer)
Form 4/A
12/17/2020
8:06 AM
CRISPR Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/14/2020
6:11 PM
Bolzon Bradley J PhD (Reporting)
CRISPR Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2020
3:05 PM
CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2020
7:16 AM
CRISPR Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2020
7:12 AM
CRISPR Therapeutics (Filer)
Form 424B5
12/10/2020
3:35 PM
CRISPR Therapeutics (Issuer)
KASINGER JAMES R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2020
6:54 PM
Bolzon Bradley J PhD (Reporting)
CRISPR Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2020
6:50 AM
CRISPR Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/03/2020
3:32 PM
CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2020
3:26 PM
CRISPR Therapeutics (Issuer)
Novak Rodger (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2020
8:14 AM
CRISPR Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/02/2020
4:30 PM
Bolzon Bradley J PhD (Reporting)
CRISPR Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/28/2020
7:08 AM
CRISPR Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/28/2020
7:03 AM
CRISPR Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/21/2020
7:58 AM
CRISPR Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/13/2020
3:44 PM
CRISPR Therapeutics (Issuer)
Novak Rodger (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/09/2020
12:51 PM
ARK Investment Management LLC (Filed by)
CRISPR Therapeutics (Subject)
Form SC 13G
10/06/2020
4:48 PM
CRISPR Therapeutics (Issuer)
TOMSICEK MICHAEL JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2020
4:45 PM
CRISPR Therapeutics (Issuer)
CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2020
4:38 PM
CRISPR Therapeutics (Issuer)
Klein Lawrence Otto (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2020
4:34 PM
CRISPR Therapeutics (Issuer)
KASINGER JAMES R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2020
4:32 PM
CRISPR Therapeutics (Issuer)
Ho Tony W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/24/2020
5:09 PM
Bolzon Bradley J PhD (Reporting)
CRISPR Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/22/2020
7:10 PM
Bolzon Bradley J PhD (Reporting)
CRISPR Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2020
4:05 PM
CRISPR Therapeutics (Subject)
Versant Venture Capital IV, L.P. (Filed by)
Form SC 13D/A
09/18/2020
3:30 PM
Bolzon Bradley J PhD (Reporting)
CRISPR Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2020
7:00 PM
Bolzon Bradley J PhD (Reporting)
CRISPR Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2020
8:49 PM
Bolzon Bradley J PhD (Reporting)
CRISPR Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2020
10:04 AM
Capital International Investors (Filed by)
CRISPR Therapeutics (Subject)
Form SC 13G
09/10/2020
1:54 PM
Capital International Investors (Filed by)
CRISPR Therapeutics (Subject)
Form SC 13G
09/03/2020
8:21 PM
Bolzon Bradley J PhD (Reporting)
CRISPR Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2020
3:46 PM
CRISPR Therapeutics (Issuer)
TOMSICEK MICHAEL JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2020
3:44 PM
CRISPR Therapeutics (Issuer)
Novak Rodger (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2020
3:42 PM
CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2020
3:11 PM
CRISPR Therapeutics (Issuer)
Novak Rodger (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2020
3:20 PM
CRISPR Therapeutics (Issuer)
TOMSICEK MICHAEL JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/27/2020
3:46 PM
CRISPR Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
07/27/2020
3:41 PM
CRISPR Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/27/2020
3:35 PM
CRISPR Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2020
4:26 PM
CRISPR Therapeutics (Subject)
GLAXOSMITHKLINE PLC (Filed by)
Form SC 13D/A
07/09/2020
3:00 PM
CRISPR Therapeutics (Issuer)
Novak Rodger (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2020
3:14 PM
CRISPR Therapeutics (Issuer)
Novak Rodger (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2020
4:12 PM
CRISPR Therapeutics (Filer)
Form 424B5
06/29/2020
3:24 PM
CRISPR Therapeutics (Filer)
Form 424B5
06/26/2020
3:33 PM
CRISPR Therapeutics (Issuer)
Klein Lawrence Otto (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2020
3:28 PM
CRISPR Therapeutics (Issuer)
Novak Rodger (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2020
6:02 PM
Bolzon Bradley J PhD (Reporting)
CRISPR Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2020
4:58 PM
CRISPR Therapeutics (Issuer)
Ho Tony W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
6:49 PM
Behbahani Ali (Reporting)
CRISPR Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
3:45 PM
CRISPR Therapeutics (Issuer)
Treco Douglas A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
3:42 PM
CRISPR Therapeutics (Issuer)
Treco Douglas A (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/15/2020
3:37 PM
CRISPR Therapeutics (Issuer)
High Katherine A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
3:33 PM
CRISPR Therapeutics (Issuer)
Greene John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 9/18/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.